-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Original title: What you eat matters! Dietary supplements with lutein and zeaxanthin in place of beta-carotene slow AMD progression, study confirms
Editor's note: The Age-Related Eye Disease Study (AREDS and AREDS2) determined that dietary supplements can slow the progression of age-related macular degeneration (AMD), based on data from the National Eye Institute
Editor's note: The Age-Related Eye Disease Study (AREDS and AREDS2) determined that dietary supplements can slow the progression of age-related macular degeneration (AMD), based on data from the National Eye Institute
AREDS Study Shows: Beta-Carotene-Containing Dietary Supplement Formulations Can Significantly Slow AMD Progress AREDS Study Shows: Beta-Carotene-Containing Dietary Supplement Formulations Can Significantly Slow AMD Progress Dietary supplement formulation can significantly slow AMD progression
The AREDS study, originally initiated in 1996, showed that dietary supplements (500㎎ vitamin C, 400 IU vitamin E, 2㎎ copper, 80㎎ zinc, and 15㎎ beta-carotene) significantly slowed the progression of AMD from intermediate to advanced stages.
The AREDS study, originally initiated in 1996, showed that dietary supplements (500㎎ vitamin C, 400 IU vitamin E, 2㎎ copper, 80㎎ zinc, and 15㎎ beta-carotene) significantly slowed the progression of AMD from intermediate to advanced stages.
Because beta-carotene increased the risk of lung cancer in current smokers in two NIH-backed studies, said lead author Professor Emily Chew, director of the Division of Epidemiology and Clinical Applications at the National Eye Institute
AREDS2 study shows that dietary supplements with lutein and zeaxanthin instead of beta-carotene are better choices AREDS2 study shows: lutein and zeaxanthin are better choices for dietary supplements instead of beta-carotene Dietary supplements with zeaxanthin instead of beta-carotene are better options
In the AREDS2 study, starting in 2006, Prof.
In the AREDS2 study, starting in 2006, Prof.
A follow-up study showed that people who initially received dietary supplements containing lutein/zeaxanthin had a lower risk of developing advanced AMD Lower risk of progression to advanced AMD Follow-up study shows lower risk of progression to advanced AMD in people initially receiving lutein/zeaxanthin-containing dietary supplements
In the new report, researchers followed 3,883 of the original 4,203 AREDS2 participants for five years after the AREDS2 study ended in 2011, collecting information on whether participants' AMD progressed to an advanced stage and whether they were diagnosed Lung cancer
In the new report, researchers followed 3,883 of the original 4,203 AREDS2 participants for five years after the AREDS2 study ended in 2011, collecting information on whether participants' AMD progressed to an advanced stage and whether they were diagnosed Lung cancer
Prof Chew concluded that these findings confirm that converting beta-carotene to lutein and zeaxanthin in dietary supplement formulations is the right choice
Reference: https://eyewire.
View more exciting content
(Source: Editorial Department of International Ophthalmology Times)
(Source: Editorial Department of International Ophthalmology Times)Copyright Notice
Copyright Notice Copyright NoticeCopyright belongs to International Ophthalmology News
Copyright belongs to International Ophthalmology News
point share point share
Favorites
point favorite point favoriteLike
Like, like, like, likeclick to watch
point to see point to seeEditor:
